About 100 reports

Global Liquid Biopsy Market for Gastric Cancer, 2019-2030 ##. ##. ##. ##. ##.

  • Biotech Diagnostics
  • Genetic Testing
  • United States
  • World
  • Market Size

Table ##.

  • Biotech Diagnostics
  • World
  • Forecast
  • Market Size
  • Cancer Genetics, Inc.

Some of the major targets are gastric cancer, bladder cancer, breast cancer, and lung cancer among others.

  • Biotech Diagnostics
  • Drug Development
  • World
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • 5.5.2 Phase II Clinical Trails

Ion 2016, cancer incidences in more than ## in Germany.

  • Biotech Diagnostics
  • Europe
  • World
  • Forecast
  • Market Size
  • 6.3 LIQUID BIOPSY MARKET: COMPETITIVE TECHNOLOGY PORTFOLIO

(US) cfDNA Blood based mutations Breast cancer, malignant melanoma, prostate, lung, gastrointestinal, and pancreatic cancers ## ## ## ## ## Biotheranostics (US) CTC Breast cancer, melanoma, and gastric cancer.

  • Biotech Diagnostics
  • United States
  • Market Size
  • Biocept, Inc.
  • Biodesix Inc.
  • MARKET SIZING 2017

IT IS A SINGLE COMPREHENSIVE TEST THAT CAN DETERMINE AN INDIVIDUAL' S HEREDITARY CANCER RISK FOR VARIOUS TYPES OF CANCERS SUCH AS BREAST CANCER, UTERINE CANCER, PROSTATE CANCER, GASTRIC CANCER, PANCREATIC CANCER, MELANOMA

  • Biotech Diagnostics
  • bioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Myriad Genetics, Inc.
  • QIAGEN N.V.

The collaboration has ensured Day-One patient access to FDA-approved molecular tests paired with newly approved drugs for cancer.

  • Biotech Diagnostics
  • World
  • Forecast
  • Market Size
  • Agilent Technologies, Inc.
  • Revenue in USD million, In Situ Hybridization (ISH), 2017-2025
  • COMPANION DIAGNOSTICS MARKET

France has been one of the pioneers of cancer research in Europe.

  • Biotech Diagnostics
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.

It offers assays for solid tumor indications, such as breast cancer, non-smal cel lung cancer, smal cel lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma.

  • Biotech Diagnostics
  • World
  • Forecast
  • Market Size
  • MDxHealth SA

I THINK [ONE] BEING WORKED ON BY DAIICHI SANKYO WILL ENABLE [THIS] FOR HER## POSITIVE CANCERS AND GET APPROVAL.

  • Biotech Diagnostics
  • Abbott Molecular Inc.
  • Foundation Medicine, Inc.
  • Roche Group
  • Ventana Medical Systems, Inc.

Biocept offers OncoCEE-BR test for breast cancer, OncoCEE-GA test for gastric cancer and OncoCEE-LU for non-small cell lung cancer.

  • Biotech Diagnostics
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

LIST OF FIGURES FIGURE ##.

  • Biotech Diagnostics
  • North America
  • Forecast
  • Market Size
  • Agilent Technologies, Inc.

In the international market, the company carries out its sale through subsidiaries, or various distributors or representatives. ##. ##. ## BUSINESS DESCRIPTION ##. ##. ## FINANCIAL OVERVIEW Source: Company annual reports and The Insight Partner Analysis ##. ##. ## PRODUCT PORTFOLIO PRODUCT SSel XT HS

  • Biotech Diagnostics
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.

DAKO' S HER## FISH PHARMDX KIT IS USED TO DETECT BREAST AND GASTRIC CANCER BY ASSESSING THE HER## GENE.

  • Biotech Diagnostics
  • United States
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.

You can easily book an appointment with one online.

  • Biotech Diagnostics
  • United States
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • CTCS-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT

FOR GASTRIC CANCER, BESIDES HER##, THE TEST IDENTIFIES THE AMPLIFICATION OF MET ALSO VIA FISH ON CTCS.

  • Biotech Diagnostics
  • World
  • Epigenomics AG
  • QIAGEN N.V.
  • Roche Group

Lynn Cancer Institute is one of the largest cancer ##.

  • Biotech Diagnostics
  • United States
  • Cepheid
  • PerkinElmer, Inc.
  • Quidel Corporation

Lynn Cancer Institute is one of the largest cancer ##.

  • Biotech Diagnostics
  • United States
  • Cepheid
  • PerkinElmer, Inc.
  • Quidel Corporation
  • LIQUID BIOPSY MARKET: SHARE BY INDICATION, 2017, 2030 (%)
  • 12.3.1.3. LIQUID BIOPSY MARKET FORECAST: DISTRIBUTION BY TYPE OF MARKER

GASTRIC CANCER TEST EMPLOYS THE CTC HER## FISH TEST FOR ANALYSIS OF CTCS IN GASTRIC CANCER PATIENTS.

  • Biotech Diagnostics
  • North America
  • United States
  • Market Size
  • Biocept, Inc.

As of 2013, there have been ## sites for upper gastrointestinal cancer (including esophageal cancer, cardiac cancer and gastric cancer), ## sites for colorectal cancer, ## sites for liver cancer, ## sites for nasopharyngeal cancer and ## s

  • Biotech Diagnostics
  • HPV Testing
  • China
  • East Asia
  • OriGene Technologies, Inc.
  • COMPANION DIAGNOSTICS MARKET FOR GASTRIC CANCER, BY COUNTRY, 2020-2025 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2020-2025 (USD MILLION)

PLAYERS IN THIS MARKET ARE FOCUSING ON DEVELOPING TESTS AND KITS FOR GASTRIC CANCER INDICATIONS IN ORDER TO CATER TO UNMET DEMANDS; A NUMBER OF CDX TESTS AND KITS HAVE ALSO RECEIVED APPROVALS FOR GASTRIC CANCER INDICATIONS.

  • Biotech Diagnostics
  • Cancer
  • North America
  • United States
  • Market Size

GIVANTAGE HEREDITARY COLORECTAL CANCER TEST, WHICH INCLUDES ## GENES PREDOMINANTLY ASSOCIATED WITH COLON AND GASTRIC CANCERS.

  • Biotech Diagnostics
  • Bina Technologies, Inc.
  • Edico Genome
  • Illumina, Inc.
  • Knome, Inc.

Clinical Investigation Using Cell-Free Circulating Tumor DNA for Different Indications ##. ## Lung Cancer ##. ## Breast Cancer ##. ## Colorectal Cancer ##. ## Melanoma ##. ## Gastric Cancer ##. ## Prostate Cancer ##. ## Brain Cancer ##. ## Detection & Monit

  • Biotech Diagnostics
  • Biotechnology
  • Diagnostics
  • Genetic Testing
  • Medical Biotechnology

BIOCEPT OFFERS ONCOCEE-BR TEST FOR BREAST CANCER, ONCOCEE-GA TEST FOR GASTRIC CANCER AND ONCOCEE-LU FOR NON-SMALL CELL LUNG CANCER.

  • Biotech Diagnostics
  • Biocept, Inc.
  • CareDx, Inc.
  • Illumina, Inc.
  • Natera, Inc.

Molecular Diagnostics 2016 Market Study ##.

  • Biotech Diagnostics
  • Biotechnology
  • Diagnostics
  • Molecular Diagnostics
  • World

More than ## disease areas have been investigated and these include (in alphabetical order) AIDS, Alzheimer' s Disease, Antibiotic Resistance, Asthma, Autoimmune Disease, Avian Influenza, Cancer–Bladder, Cancer–Breast, Cancer–Cervical, Cancer–Colon,

  • Biotech Diagnostics
  • Diagnostics
  • Medical Biotechnology
  • Molecular Diagnostics
  • World

This method can detect antigens within ##-## hours.

  • Biotech Diagnostics
  • In Vitro Diagnostics
  • United States
  • Beckman Coulter, Inc.
  • Roche Group

THE TEST WAS RECENTLY EVALUATED IN A STUDY INVOLVING ## INDIVIDUALS, INCLUDING HEALTHY, COPD AND LUNG CANCER PATIENTS, AND WAS CAPABLE OF DISTINGUISHING BETWEEN CANCER AND NON-CANCER PATIENTS WITH ##% ACCURACY.

  • Biotech Diagnostics
  • Illumina, Inc.
  • Mirna Therapeutics, Inc.
  • QIAGEN N.V.
  • Sigma-Aldrich
  • Untitled
  • 7.6 IN SITU HYBRIDIZATION

ISH-BASED DIAGNOSTICS ARE ALSO USED TO DETECT MUTATIONS IN PATIENTS WITH GASTRIC CANCER.

  • Biotech Diagnostics
  • North America
  • United States
  • Forecast
  • QIAGEN N.V.